Category: Insights

Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984

This article was originally published by Garth Boehm, Lixin Yao, Liang Hana, and Qiang Zheng in Acta Pharmaceutica Sinica under a creative commons license. Abstract The key events in the…
The post Development of the generic drug industry in the US afte…


Customer Success: How do we identify generic entrants before they get FDA approval?

DrugPatentWatch can help identify generic entrants at the earliest stages Many clients come to DrugPatentWatch seeking to identify generic entrants well before they launch. CDMOs, equipment manufacturers, regulatory consultants, and…
The post Customer …


Get email updates

Get new actionable insights and updates from BiotechBlog

Do NOT follow this link or you will be banned from the site!